LeadIQ logo
Learn more at LeadIQ.com

Insights

Immunotherapy Advancements invoX Pharma focuses on developing immuno-oncology therapies using proprietary technology. This offers a potential sales opportunity for biopharmaceutical companies looking to enhance their oncology product portfolio.

Respiratory Device Innovation With a highly effective soft mist inhalation device for respiratory diseases, invoX Pharma presents an opportunity for medical device companies looking to collaborate on innovative drug-device combination products.

Next-Generation Vaccines invoX Pharma's investment in developing next-generation mRNA vaccines indicates a potential sales opportunity for vaccine manufacturers seeking partnerships to advance vaccine technologies.

Strategic Acquisitions Having acquired F-star Biotechnology, invoX Pharma displays an interest in expanding its bispecific discovery platform. This presents a potential sales opportunity for companies specializing in bispecific antibodies and clinical programs.

Global Reach With activities in the UK, EU, and US, invoX Pharma offers a sales opportunity for suppliers of research tools, clinical trial services, and logistics companies looking to collaborate with a growing global biopharmaceutical firm.

Similar companies to invoX Pharma

invoX Pharma Tech Stack

invoX Pharma uses 8 technology products and services including Optimise, SAS, Qurate, and more. Explore invoX Pharma's tech stack below.

  • Optimise
    Affiliate Advertising Networks
  • SAS
    Business Intelligence
  • Qurate
    Content Marketing
  • Microsoft
    Miscellaneous
  • Open Graph
    Miscellaneous
  • PHP
    Programming Languages
  • Yoast SEO
    Search Engines
  • WP Fastest Cache
    Web Platform Extensions

invoX Pharma's Email Address Formats

invoX Pharma uses at least 1 format(s):
invoX Pharma Email FormatsExamplePercentage
First.Last@invoxpharma.comJohn.Doe@invoxpharma.com
90%
FLast@invoxpharma.comJDoe@invoxpharma.com
7%
First.MiddleLast@invoxpharma.comJohn.MichaelDoe@invoxpharma.com
2%
First.Middle@invoxpharma.comJohn.Michael@invoxpharma.com
1%

Frequently Asked Questions

Where is invoX Pharma's headquarters located?

Minus sign iconPlus sign icon
invoX Pharma's main headquarters is located at Westworks, 195 Wood Lane, London Suite 2, First Floor London, England W12 7FQ GB. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is invoX Pharma's official website and social media links?

Minus sign iconPlus sign icon
invoX Pharma's official website is invoxpharma.com and has social profiles on LinkedIn.

How much revenue does invoX Pharma generate?

Minus sign iconPlus sign icon
As of October 2024, invoX Pharma's annual revenue reached $35M.

What is invoX Pharma's NAICS code?

Minus sign iconPlus sign icon
invoX Pharma's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does invoX Pharma have currently?

Minus sign iconPlus sign icon
As of October 2024, invoX Pharma has approximately 201 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: B. T.Chief Scientific Officer: G. O.Chief Financial Officer: J. H.. Explore invoX Pharma's employee directory with LeadIQ.

What industry does invoX Pharma belong to?

Minus sign iconPlus sign icon
invoX Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does invoX Pharma use?

Minus sign iconPlus sign icon
invoX Pharma's tech stack includes OptimiseSASQurateMicrosoftOpen GraphPHPYoast SEOWP Fastest Cache.

What is invoX Pharma's email format?

Minus sign iconPlus sign icon
invoX Pharma's email format typically follows the pattern of . Find more invoX Pharma email formats with LeadIQ.

When was invoX Pharma founded?

Minus sign iconPlus sign icon
invoX Pharma was founded in 2021.
invoX Pharma

invoX Pharma

Pharmaceutical ManufacturingEngland, United Kingdom201-500 Employees

invoX Pharma is a research-driven global biopharmaceutical company and our mission is to improve lives by creating access to innovative medicines.

We use next-generation technology platforms that take clinically validated approaches and incorporate innovative and novel features. This enables us to discover and develop potential therapies against promising targets. 

Our diversified pipeline consists of both clinical- and pre-clinical-stage programmes that address the unmet needs of patients globally and our R&D activities are focused in two areas.

In Oncology R&D, we develop immuno-oncology therapies using proprietary technology that can be applied to a wide range of cancers. Our pipeline includes three bispecific antibodies in clinical development and multiple additional projects in preclinical development.

In Respiratory R&D, our Respiratory Innovation Centre has developed a highly effective soft mist inhalation device which delivers medication to the lungs more effectively than powder or spray inhalers. We are using this to develop drug-device combination products for respiratory diseases.

Incorporated in March 2021, we have R&D, Clinical Development and Business Development activities in the UK, EU and US. 

Section iconCompany Overview

Headquarters
Westworks, 195 Wood Lane, London Suite 2, First Floor London, England W12 7FQ GB
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2021
Employees
201-500

Section iconFunding & Financials

  • $10M$50M

    invoX Pharma's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    invoX Pharma's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.